Skip Navigation Bar
Robert Q. Marston Articles and Speeches 1964-1973
full text File Size: 39 K bytes | Add this to my bookbag

Box | Folder Title
 
Series 4: Subject Files, 1931-2000 [series]:
12 1
Indexes: Keysort classifications, [ca. 1990-95]
 
Hypertension [H], 1939-96 [subseries]:
 
Saluretic Agents [H-1], 1953-91 [subseries]:
12 2-3
Chlorothiazide - Mechanism of action [34.1], 1957-89
12 4
Thiazide - Effects on LVH [34.2], 1982-87
12 5
Thiazide drugs [32], 1958-69, 1984
12 6
Mercurials [31], [after 1985]
12 7
Thiazides' effect on calcium [30], 1990-91
12 8
Aldosterone antagonists [29], 1953-80
12 9
Polythiazide [28], 1961-63
12 10
Non saluretic thiazides [27], 1961-68
12 11
Triamterene and MK870 [26], 1961-85
12 12
Furosemide [25], 1964-79
12 13
Ticrynafen [24], 1978-80
 
Blocking Agents [H-2], 1946-96 [subseries]:
12 14
Hexamethonium - Pharmacology [34A], 1950-60
12 15
Hexamethonium - Treatment, Clinical [34B], 1950-56
12 16
Hexamethonium and Hydralazine [34C], 1952-55
12 17
Hexamethonium and Rauwolfia [34D], 1953
12 18
Hexamethonium - Correspondence and reports [34E], 1951-64
12 19
Pentolinium - Pharmacology [33A], 1956-60
12 20
Pentolinium - Clinical [33B], 1953-56
12 21
Pentolinium - with Hydralazine [33C], 1955
12 22
Pentolinium - with Rauwolfia [33D], 1954-55
12 23
Pentolinium - Correspondence and reports [33E], 1954-55
12 24
Chlorisondamine - Pharmacology [32A], 1954-58
12 25
Chlorisondamine - Treatment [32B], 1955-57
12 26
Chlorisondamine - Correspondence and reports [32C], 1954-56
12 27
Mecamylamine [31], 1955-60
12 28
Miscellaneous blocking drugs - Arfonad [30], 1946-61
12 29
Ganglion blocking agents - Trimethidinium methosulfate [30], 1958-62
12 30
Pempidine [30], 1960
12 31-32
Guanethidine [29], 1959-76
12 33
Darenthin (or Bretylium) [28], 1959-62
12 34
Iproniazid and Catron [27], 1959-63
12 35
Pargyline [26], 1961-64
12 36
Ganglion blocking agents - Literature, side effects, toxicity, tolerance [25], 1948-63
12 37
Ganglion blocking agents - General chemical and pharmacological [25], 1947-63
12 38
Ganglion blocking agents - Clinical uses other than in hypertension [25], 1948-56
12 39
Sympatholytic, selective [23], 1960-66
12 40
General [22], 1948-74
12 41
Phentolamine (Regitine) [21], 1965
12 42-43
Adrenergic blockers - Various (includes Labetalol) [19], 1949-85
12 44
Aldomet [18], 1961-88
12 45-47
Beta adrenergic blockers [17], 1966-96
12 48-49
Propranolol [16], 1966-83
12 50
Angiotensin blockers - including Saralasin [15], 1984-95
12 51
Angiotensin blockers - Enalapril 421 or 521 [15A], 1978-90
12 52
Losartan [15B], 1992-95
13 1
Clonidine [14], 1975-85
13 2
Guanabenz [13], 1981-83
13 3
Thiocyanate [12], [after 1970]
13 4
Calcium Channel Block [7], 1995
13
Etiology and Pathogenesis [H-3], 1948-95 [subseries]:
13 5-6
Renin - Renal pressor theory [34], 1959-90
13 7
Kidney in [hypertension] - Pyelonephritis [33], 1959-70
13 8
Unilateral renal vascular disease [32], 1956-87
13 9
Renoprival [31], 1951-65
13 10
Renal, other [30], 1955-86
13 11-12
Salt in hypertension [29], 1955-87
13 13-14
K+ in diet and Na/K+ Ratio. Also, calcium [29A], 1975-88
13 15
Salt sensitivity - Potassium [29B], 1972-95
13 16
Neural [28], 1975-94
13 17
Baroreceptor theories [27], 1948-91
13 18
Sympathetic nerves [26], 1949-83
13 19
Brain and post, pituitary [25], 1958-88
13 20-21
Emotional stress - Neurogenic, other [ 24], 1950-86
13 22
Adrenal cortex [23], 1949-91
13 23
Hormonal, adrenal medulla [22], 1961-88
13 24
Pituitary in [hypertension] [21], 1948-50
13 25
Hormonal, other [20], 1955-82
13 26
Coarctation of aorta [19], 1951-88
13 27
Hypertension and heredity [18], 1953-87
13 28
Environment [17], 1957-77
13 29
Ca, Mg [16], 1985
13 30-31
Other ions than Na+ - Mg++, Ca++, K+, Cl [15], 1961-94
13 32-33
Fluid volumes in [hypertension] [14], 1952-93
13 34-38
Epidemiological studies [13], 1953-91
13 39-40
Epidemiology - Racial differences [13A], 1956-75
13 41
Exaggerated natriuresis in [hypertension] [12], 1949-62
13 42
Toxemia of pregnancy [11], 1964-84
13 43
Cardiogenic [10], 1962-84
14 1
Miscellaneous [9], 1962-87
14 2
History of hypertension [8] [photograph], [ca. 1960-64]
14 3
Reviews, general [7], 1976-80
14 4
Kallikrein and prostaglandins [6], 1968-85
14 5
Fast-twitch muscle fibers in hypertension - lower body compression [5], 1979-84
14 6
Atrial natriuretic factor [4], 1984-90
14 7
Insulin resistance diabetes [3], 1986-91
14 8
Obesity [3 - crossed out in index], 1987
14 9
Endothelium relaxing factor, etc. [2], 1989
 
Other Antihypertensive Agents, General Treatment Control Studies [H-4], 1940-96 [subseries]:
14 10
Hydralazine - Literature - Clinical [34], 1951-83
14 11
Hydralazine - Literature - Pharmacology [34], 1951-81
14 12
Hydralazine - Literature - Toxicity [34], 1953-82
14 13
Hydralazine - like agents [33], 1945-49
14 14
Rauwolfia - Side effects [32], 1954-83
14 15
Rauwolfia - Crude root [31], 1955-63
14 16
Reserpine - Pharmacology [29], 1954-77
14 17
Reserpine - Antiarrhythmic activity [29], 1955-66
14 18-19
Rauwolfia - Reserpine - Treatment [29], 1954-84
14 20
Rauwolfia - Various alkaloids [28], 1955-65
14 21
Veratrum - Pharmacology [27], 1949-66, 1983
14 22
Veratrum - Viride - Clinical treatment [26], 1948-54
14 23
Control studies [25], 1960-79, 1996
14 24
Veratrum - Other alkaloids - Protoveratrine, etc., Viscum album [24], 1949-59
14 25
Veratrum - Neogermitrine assay data [24], 1950
14 26
Sympathectomy [21], 1940-61
14 27
Miscellaneous [20], 1948-69
14 28
Azide Sodium - Literature [20], 1954-61
14 29
Hypertensive agent IN-66 (Irwin, Neisler and Co.) [20] [Restricted], 1952-1953
14 30
Adrenalectomy [19], 1951-54
14 31-34
Treatment Dietary [18], 1948-57, 1973-91
14 35
Surgery of renal hypertension [17], 1963
14 36
Renal transplants [16], 1964-65
14 37
Diazoxide [15], 1976
14 38
General discussion and review [14], 1974-81
14 39-40
Prazosin [13], 1974-95
14 41
Minoxidil [12], 1973-81
14 42
Cost of drugs [11], 1978-83
14 43-46
FDA and drug regulations [10], 1971-83
15 1
Psychophysiological techniques [9], 1972-84
15 2
National programs [8], 1977-82
15 3
Calcium antagonists - General [7A], 1977-92
15 4
Calcium antagonists - Nitrendipine [7C], [1984-85]
15 5
Calcium antagonists - Diltiazem [7D], 1982-89
15 6
Verapramil [7E], 1982-87
15 7
Exercise [6], 1978-86
15 8
Reverse titration [5], 1967-82
15 9
Serotonin antagonists [4], 1984-86
 
Clinical [H-5], 1943-93 [subseries]:
15 10
General discussion of disease - Reviews [34], 1946-50, 1970
15 11
Subarachnoid hemorrhage [33], 1982
15 12
Left Ventricular Hypertrophy / ECG or VCG in Hypertension [32], 1962-97
15 13
Prognosis, untreated [31], 1943-74
15 14
Treatment effect on prognosis - Indications for Rx mild [30], 1956-88
15 15
Prognosis with surgical [29], 1950-62
15 16
Reactivity in borderline hypertension [28], 1955-90
15 17
Practical details of drug treatment, home BPs, cost, etc. [27], 1974-88
15 18
Antihypertensive Drugs - Treatment, general [26], 1959-93
15 19
Systolic hypertension [25], 1982-88
15 20
Effects of Rx on organic damage (Cardiac, renal) [24] [photograph], 1951-91
15 21-22
Blood pressure recording [23], 1954-90
15 23
Blood pressure - Casual versus basal [22], 1953-89
15 24
Ambulatory BP monitoring [22A], 1981-90
15 25
Miscellaneous symptoms (Headache, etc.) [21], 1962, 1986-88
15 26
Uric acid, gout, gouty nephritis [20], 1963, 1966
15 27
Hypertensive encephalopathy and crisis [19], 1975-92
15 28
Dissecting aneurysm [18], 1968-82
15 29-30
Clinics for hypertension - Detection, costs [17], 1972-98
15 31
Hypertension in children [16], 1960-88
15 32
Physician education - Tests, nurse education, etc. [15], 1959-79
15 33
Hypertension in the aged [14], 1970-92
15 34-35
Obesity - Weight reduction [13], 1967-92
15 36
Comments on trials [12A], 1974-90
15 37-38
Compliance [11], 1967-87
15 39
Blacks and other race [10], 1976-89
15 40
Low lipid diets [9], 1981-87
15 41
Mental and behavioral [with and without] Rx [8], 1971-89
15 42
Stepdown of Rx [7], 1956, 1975-89
15 43
Left Ventricular Hypertrophy [6], 1979-94
15 44
The J curve [5], 1985-91
15 45
Circadian rhythm [4], 1992
15 46
Kidney in hypertension [3], 1988-92
15 47
Diabetes and HBP - Nephropathy [2], 1989-93
 
Atherosclerosis [H-6], 1949-93 [subseries]:
15 48
Atherosclerosis - Cholesterol in [34], 1957-89
15 49
Atherosclerosis and L[ow]-D[ensity] L[ipoproteins] [33], 1982
15 50
Atherosclerosis and dietary fat [32], 1955-90
15 51
Physical activity [31], 1960, 1981-87
15 52
Coronary [30], 1963-82
16 1
Lipids other than cholesterol [29], 1949-59, 1982
16 2
MER 29 - Cholesterol synthesis antagonists [28], 1960-62
16 3
Thyroid substances [27], 1949-57
16 4
Vessel wall factors [26], 1958-93
16 5-6
Miscellaneous drug treatment [25], 1957-91
16 7
Reviews [24], 1976-89
16 8-10
Epidemiology of coronary artery disease [23] [photographs], [1967]-88
16 11
By-pass surgery [22], 1977-90
16 12
Apolipoproteins [21], 1986
16 13
Blood clotting factors and prevention of M[yocardial] I[nfarction] [21], 1980-82
16 14
H[igh]-D[ensity] L[ipoprotein] [20], 1980-91
16 15
C[oronary] H[eart] D[isease] mortality - secondary prevention trials [19], 1984
16 16
Exercise [18], 1982-84
16 17
Acute Miyocardial] I[nfarction] [17], 1988-91
16 18
Hypertension and accelerated atherosclerosis [16] [photograph], 1960-82
16 19
Primary prevention control trials [15], 1984-91
16 20
Treatment of coronary occlusion with anticoagulants [14], 1985-90
16 21
Angina [13], 1984
16 22
Smoking [11], 1991
 
Organ Systems In and Types of Hypertension [H-7], 1939-89 [subseries]:
16 23
Malignant - Untreated [34], 1939, 1948-79
16 24
Malignant - Treated [33] [photographs], 1953-67
16 25
General [32], 1961
16 26
Kidney in [31], 1941-78
16 27
Heart in [30], 1958-89
16 28-29
Brain in [29], 1945-88
16 30
Large vessels in [28], 1955-88
16 31-32
Small vessels in [27], 1956-89
16 33
Other organs in [26], 1952-60
16 34-35
Pheochromocytoma [25], 1954-85
16 36
Fundi [24], 1962, 1980-85
16 37
Adrenal cortex in [23], 1941-75
16 38
Atherosclerosis in [22], 1959-87
16 39
Classification [21], 1946-58
16 40
S[pontaneously] H[ypertensive] R[at] [20], 1956-81
16 41
Veins - Venous tone [19], 1978-87
16 42
Vascular endothelium [18], [ca. 1980-89]
 
Hemodynamics [T], 1941-91 [subseries]:
 
Heart [T-1], 1948-91 [subseries]:
16 43
Theoretical concepts - New method [34.1], 1963
16 44-45
Output [33], 1948-63, 1977-84
16 46
Flow [32], 1949-62
16 47
Pressure [31], 1948-64
16 48
Velocity [30], 1962, 1980
16 49
Volume [29], 1955-64, 1991
16 50
Resistance [27], 1963, 1979
16 51
Work [26], 1963
16 52
O2 Consumption [24], 1965
16 53
Metabolism plus pH plus myogenic response [23], 1962
16 54
Electrical phenomena [21], 1959
16 55
Methods - Clearance or Fick [20], 1953
16 56
Methods - Radioisotopic tracers [18], 1980
16 57
Methods - Volume dilution [17], 1954-63
16 58
Methods - Electrocardiography [16], 1959
16 59
Methods - Colorimetric [14], 1961
16 60
Blood oxygen and CO2 [13], 1963
16 61
Elasticity of vessels [12], 1955-62
16 62
Pulse wave contours [10], 1961-62
16 63
Methods - Miscellaneous [8], 1961
 
Small Vessels [T-2], 1941-87 [subseries]:
17 1
Flow [32], 1955-87
17 2
Pressure [31], 1941, 1956
17 3
Volume [29], 1960-64
17 4
Resistance [27], 1960-65
17 5
Anatomical studies [22], 1957
17 6
Methods - Plethysmographic, or other physical [19], 1959-62
17 7
Methods - Radioisotopic tracers [18], 1963
17 8
Nervous control [13], 1963-68
17 9
Electrolytes in relation to [small vessels] [11], 1960
 
Brain [T-3], 1960-61 [subseries]:
17 10
Flow [32], 1960-61
 
Kidney [T-4], 1951-82 [subseries]:
17 11
Flow [32], 1951-82
17 12
Volume [29], 1956-58
17 13
Temperature [28], 1962
17 14
Methods - Radioisotopic tracers [18], 1956-60
 
Splanchnic Minus Renal [T-5], 1949-63 [subseries]:
17 15
Flow [32], 1949-63
17 16
Pressure [31], 1959-63
17 17
Resistance [27], 1962
 
Coronary Vessels [T-6], 1959-65 [subseries]:
17 18
Flow [32], 1964-65
17 19
Methods - Radioisotopic disease [18], 1961-64
17 20
Methods - X-Ray [15], 1959-62
 
Venous System [T-7], 1952-64 [subseries]:
17 21
Flow [32], 1959
17 22
Pressure [31], 1952-55
17 23
Volume [29], 1955-64
17 24
Resistance [27], 1962
17 25
Methods - Plethysmographic, or other physical [19], 1957
 
Extremity - Total Limb or 9 plus 10 [T-8], 1959 [subseries]:
17 26
Methods - Plethysmographic, or other physical [19], 1959
 
Extremity - Skin or Digit [T-9], 1960-74 [subseries]:
17 27
Theoretical concepts [34], 1968
17 28
Flow [32], 1962-64
17 29
Methods - Plethysmographic, or other physical [19], 1960
17 30
Electrolytes in Relation To [11], 1974
 
Extremity - Muscle or Limb Segment [T-10], 1958-89 [subseries]:
17 31
Flow [32], 1958-59, 1988-89
 
Multiple Organs [T-11], 1952-63 [subseries]:
17 32
Flow [32], 1961-63
17 33
Volume [29], 1952, 1961
 
Aorta and/or Large Arteries [T-13], 1957-73 [subseries]:
17 34
Flow [32], 1959-69
17 35
Pressure [31], 1959-73
17 36
Volume [30], 1962-64
17 37
Anatomical studies [22], 1957
17 38
Methods - Clearance or Fick [20], 1962
17 39
Methods - Volume dilution [17], 1965
17 40
Methods - X-Ray [15], 1961
17 41
Elasticity of vessels [12], 1960-62
17 42
Electrolytes in relation to [aorta and/or large arteries] [11], 1960
17 43
Methods - Miscellaneous [8], 1960-61
 
Pulmonary Circulation [T-14], 1949-65 [subseries]:
17 44
Flow [32], 1954-62
17 45
Pressure [31], 1949-63
17 46
Volume [29], 1960-65
17 47
Resistance [27], 1957
17 48
Elasticity of vessels [12], 1962
 
Lymphatics [T-15], 1959 [subseries]:
17 49
Pressure [31], 1959
 
Miscellaneous [U], 1931-2000 [subseries]:
 
Drugs Other than Antihypertensive Agents [U-1], 1942-86 [subseries]:
17 50
Pressor drugs - Epinephrine (Adrenaline) [29], 1957-62
17 51
Pressor drugs - Levarterenol (Norepinephrine) [28], 1953-68
17 52
Pressor drugs - Other sympathomimetic amines [27], 1954-75
17 53
Pressor drugs - Angiotensin [26], 1942, 1957-76
17 54
Pressor drugs - Derived from biological materials [24], 1960
17 55
Cardiac drugs - Digitalis [22], 1948-60
17 56
Cardiac drugs - Quinidine, Pronestyl [21], 1951-60
17 57
Serotonin [14], 1952-59
17 58
Histamine [13], 1969
17 59
Depressor polypeptides (Bradykinin, etc.) [12], 1962-63
17 60
SI Units [11], 1986
 
Studies Other than Hemodynamics [U-2], 1952-73 [subseries]:
17 61
Electrocardiograms [29], 1959
17 62
X-Ray [28], 1961
17 63
Extracellular fluid volume [26], 1952-63
17 64
Total body water [25], 1961
17 65
Total exchangeable sodium or potassium [23], 1955-61
17 66
Total blood volume [22], 1955-68
17 67
Muscle contraction, metabolism, cardiac contraction [21], 1962-63
17 68
Heart sounds and murmurs [20], 1955
17 69
Myogenic response [19], 1959-64
17 70
Electrokymography [18], 1962
17 71
Systolic time intervals [17], 1973
 
Neural Control of Circulation [U-3], 1959-82 [subseries]:
17 72
Catecholamine metabolism [15], 1963-82
17 73
Pineal, including carbolines [14], 1962
17 74
Reflexes with afferents from heart and lung [13], 1959-75
17 75
Sympathetic vasodilator nerves [10], 1961
17 76
Sympathetic vasoconstrictor nerves [9], 1959-60
17 77
General or integrated [8], 1960-63
17 78
Baroreceptors [5], 1961-63, 1978
17 79
Hypothalamus [1], 1959-61
 
Hemodynamic Techniques [U-4], 1949-87 [subseries]:
17 80
Blood Flow - Sonic [29], 1962
17 81
Blood Flow - Thermistor [28], 1949-71
17 82
Blood Flow - Electromagnetic [27], 1952-66
17 83
Blood Flow - Radiopotassium technique and similar [26], 1961-68
17 84
Blood Flow - Other special [25], 1950-61
17 85
Cardiac diameter mercury strain gauge [24], 1953
17 86
Cardiac "force" strain gauge [22], 1950-57
17 87
Blood viscosity [20], 1960-61
17 88
Electrical conductivity [19], 1959-61
17 89
Aortic or other large artery diameter - Methods other than x-ray [18], 1961
17 90
Limb Plethysmography - Strain gauge [17], 1964, 1980-84
17 91
Cardiac output by aortic pulse contour or differential pressure [16], 1949-65
17 92
Cardiac output by dye method [15], 1957-65, 1987
17 93
Blood pressure - Methods for measurement in man [14], 1959-86
17 94
Blood pressure - Methods for measurement in animals [13], 1957-66
17 95
Heart pumps [12], 1960-62
17 96
Renograms [11], 1963-71
17 97
Pulse wave velocity and contour [10], 1964
17 98
Microjuncture techniques [9], 1966
17 99
General animal technique (such as anesthesia, etc.) [8], 1963
17 100
Special animal techniques - Miscellaneous [7], 1963
17 101
Chronic implantation and catheterization technique [6], 1963
17 102
Echocardiography [5], 1971-74
 
Environmental Factors [U-5], 1955-75 [subseries]:
17 103
Cold [28], 1955-62
17 104
Exercise [24], 1975
17 105
Hemodynamics - Postural hypotension [22], 1959-62
17 106
Dissecting aneurysm [11], 1966
 
Effects of Changes Imposed on the Organism [U-6], 1940-81 [subseries]:
17 107
Exercise [29], 1954-59
17 108
Posture and postural hypertension [22], 1940-81
17 109
Smoking [21], 1959
17 110
Fever [20], 1959
17 111
Diving [19], 1962
17 112
Experimental ventricular pre-excitation [18], 1964
 
Diseases States [U-7], 1945-83 [subseries]:
17 113-114
Cardiac failure [29], 1951-83
17 115
Myocardial infarction [28], 1954-76
17 116
Valvular heart disease [27], 1955-59
17 117
Congenital heart disease [26], 1955-64
17 118
Other heart disease [25], 1955
17 119
Pulmonary embolism and infarction [24], 1965
17 120
Peripheral vascular diseases - Arterial [22], 1955-62
17 121
Peripheral vascular diseases - Venous [21], 1955
18 1
Shock [19], 1945-64
18 2
Nephritis, glomerulo and pyelo [17], 1959
18 3
Other renal disorders [16], [1962]
18 4
Cerebrovascular disorders [14], [1963]
18 5
Arteriovenous fistula [12], 1960-62
18 6
Cardiac resuscitation [11], 1962-64
18
Computers and General [U-8], 1953-83 [subseries]:
18 7
Use as methodology aid [25], 1962
18 8
Diagnostic aid - general [24], 1962
18 9
Diagnostic aid - ECG [23], 1959-61, 1983
18 10
Hydrodynamics, hydraulics [14], 1953-58
18
Transmembrane Exchange [U-9], 1955-85 [subseries]:
18 11
Transcapillary exchange - Large molecules [29], 1960-63, 1984-85
18 12
Transcapillary exchange - Na[+ ]and K[+] [27], 1957-61
18 13
Transcapillary exchange - Water [26], 1962
18 14
Cellular membrane exchange - Na[+] and K[+] [24], 1955-62
18 15
Cellular membrane exchange - Water [23], 1959
18 16
Cellular membrane exchange - Other molecules [22], 1962
18
Cooperative Studies and Medical Statistics [U-10], 1960-85 [subseries]:
18 17
Methodology of cooperative studies [29], 1961-85
18 18-19
Double blind control studies in hypertension [28], 1960-77
18 20
Medical statistics - General [27], 1961-82
18 21
Medical research [26], 1964-76
18 22
Use of animals in research [25], [after 1952]
18 23
Medical ethics [24], 1966
18
[Subjects Not Filed by Freis], 1931-2000 [subseries]:
18 24
[Antihypertensive agents], 1947-56, 1977-92
18 25
[Antihypertensive therapy and side effects], 1950, 1973-95
18 26
Apex cardiogram etc., 1959-73
18 27
Arterial distensibility in normotensive and hypertensive patients, 1962-76, 1984
18 28
Arterial elasticity, 1959-65, 1978-87
18 29-30
Arterial pulse contours - literature, 1931, 1956-68
21 2
Arterial pulse contours - literature, 1965
18 31
Arterial wall characteristics [photographs], 1954-71
18 32
Arteriosonde for assessing "basal" BP, 1956, 1976-77
18 33
[Blood flow], 1949, 1976
18 34
Cards, 1968-70
21 3-4
Chronic Bright's Disease, 1974
18 35
Circadian rhythm study, 1988-89
18 36
[Congestive heart failure], 1953-91
18 37
Conjunctival blood vessels, 1983-86
18 38-39
Diuretic hypokalemia, 1963-94
18 40
Ejection period [photograph], 1964-77
18 41
Fixed dose combinations Rx, 1998
18 42
Heart sounds, 1958-72
18 43
[Hexamethonium], 1950-51
18 44
[High blood pressure], 1959-87
18 45
Isovolumic contraction time, 1959-76
18 46
[Kidneys], 1955-58
18 47
KCG [Kinetocardiogram] [photograph], 1959-76
18 48-49
[Leukocytes], 1959-84
18 50
New projects, 1950, 1979-89
18 51
PRA response to HCTZ and BP responsiveness correlation, 1983-90
18 52
[Propranolol], 1969-73
18 53-54
Pulse wave studies, 1955-89
18 55-56
Pulse wave velocity, 1945, 1960-71, 1989-2000
18 57
Rabbit Athero, 1955-64
18 58
Salt volume and prevention of hypertension, 1953-54, 1976-93
19 1
Sodium in WBC in hypertension and after antihypertensive drugs, 1959-76
19 2
Step down, 1975-89
19 3-5
Thiazides - Hypokalemia, 1962-93
19 6
Thiazides - Other side effects, 1991
19 7
Thoughts - Ideas, 1959-60, 1976-82
19 8
Transcapillary exchange in hypertension, 1963-80